Saxagliptin for the treatment of type 2 diabetes mellitus: assessing cardiovascular data

Por Cobble, Michael E, Frederich, Robert
Publicado em 2012

A randomized controlled trial of the efficacy and safety of twice-daily saxagliptin plus metformin combination therapy in patients with type 2 diabetes and inadequate glycemic cont...

Por White, Judith L, Buchanan, Patricia, Li, Jia, Frederich, Robert
Publicado em 2014

Tolerability and efficacy of glycemic control with saxagliptin in older patients (aged ≥ 65 years) with inadequately controlled type 2 diabetes mellitus

Por Karyekar, Chetan S, Ravichandran, Shoba, Allen, Elsie, Fleming, Douglas, Frederich, Robert
Publicado em 2013

Assessment of the cardiovascular safety of saxagliptin in patients with type 2 diabetes mellitus: pooled analysis of 20 clinical trials

Por Iqbal, Nayyar, Parker, Artist, Frederich, Robert, Donovan, Mark, Hirshberg, Boaz
Publicado em 2014

The efficacy and safety of the dipeptidyl peptidase-4 inhibitor saxagliptin in treatment-naïve patients with type 2 diabetes mellitus: a randomized controlled trial

Por Frederich, Robert, McNeill, Robert, Berglind, Niklas, Fleming, Douglas, Chen, Roland
Publicado em 2012

Multiple Cytokines and Acute Inflammation Raise Mouse Leptin Levels: Potential Role in Inflammatory Anorexia

Por Sarraf, Pasha, Frederich, Robert C., Turner, Ewa M., Ma, Grace, Jaskowiak, Nora T., Rivet, Dennis J., Flier, Jeffrey S., Lowell, Bradford B., Fraker, Douglas L., Alexander, H. Richard
Publicado em 1997